tirzepatide inline cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says Most Successful Weight Loss Program. Lilly Shows Tirzepatide Superiority in

Semaglutide activates GLP-1 receptors in the hypothalamus (appetite), brainstem (fullness/nausea), pancreas (insulin), stomach (gastric emptying), and targets in the heart, liver, and kidneys

Important safety information Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic, Rybelsus, and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including MTC, a type of thyroid cancer

Try to reduce your caffeine and alcohol intake as well

During periods of drug shortage, the FDA permits 503A compounding pharmacies to produce versions of the drug to meet patient demand

The community is there

When to Reevaluate Your Weight Loss Plan It may be time to reassess if: Youve been on a stable dose for several months with no change Hunger hasnt decreased at all Fatigue, stress, or sleep issues are worsening You feel stuck despite consistent effort Reevaluation doesnt mean failure, it means adjusting the plan